Refine
Has Fulltext
- yes (21)
Is part of the Bibliography
- yes (21)
Year of publication
Document Type
- Journal article (20)
- Preprint (1)
Language
- English (21) (remove)
Keywords
- caloric restriction (4)
- mass spectrometry (4)
- LC/MS (3)
- NRF2 (3)
- methionine restriction (3)
- ATF4 (2)
- CSF (2)
- L929 (2)
- MYC (2)
- amino acid (2)
- biomarker (2)
- cerebrospinal fluid (2)
- forensic neuropathology (2)
- forensic neurotraumatology (2)
- liquid chromatography/mass spectrometry (2)
- melanoma (2)
- metabolism (2)
- metabolomics (2)
- 2-DG (1)
- 2-deoxy-D-glucose (1)
- AMP-activated protein kinase (AMPK) (1)
- Beige adipocytes (1)
- C/EBP (1)
- CHAC1 (1)
- COX2 expression (1)
- CRISPR-Cas9 (1)
- Chlamydia trachomatis (1)
- CoA (1)
- GSH (1)
- HUWE1 (1)
- IL-4 antagonists (1)
- Interleukin-4 (IL-4) (1)
- JUN (1)
- MIZ1 (1)
- NAD (1)
- Protein kinase D1 (PKD1) (1)
- Protein kinase D3 (PKD3) (1)
- SLC7A11 (1)
- activity-based probes (1)
- amino acid analogues (1)
- amino acid restriction (1)
- antagonist (1)
- arginine metabolism (1)
- atopic diseases (1)
- autophagy (1)
- biofluid (1)
- biology (1)
- biosynthetic glycosylation (1)
- cancer (1)
- cancer therapy (1)
- cathepsin (1)
- chemical glycosylation (1)
- cholesterol (1)
- colorectal cancer (1)
- contact inhibition (1)
- crotonase (1)
- crystal structure (1)
- cysteine restriction (1)
- cysteine synthase inhibitor (1)
- cytotoxic T cells (1)
- dehydrogenase (1)
- diacylglycerol (DAG) (1)
- digestive system (1)
- drug discovery (1)
- energy restriction (1)
- glioblastoma (1)
- glucose restriction (1)
- glycoengineering (1)
- glycolytic flux control (1)
- growth and differentiation factor 5 (1)
- homocysteine (1)
- infection (1)
- inflammation (1)
- integrated stress response (1)
- intrinsic metabolism (1)
- ligand-receptor complex (1)
- lipid metabolism (1)
- liver (1)
- low carb (1)
- lung cancer (1)
- lymphocyte differentiation (1)
- lysosome (1)
- melanoma malignancy (1)
- metabolome (1)
- methionine (1)
- monolayer (1)
- mouse model (1)
- neurospheres (1)
- non-small cell lung cancer (1)
- perfusion culture (1)
- pharmacology (1)
- phosphoglycolate phosphatase (1)
- proliferation (1)
- substrate channeling (1)
- thiol starvation (1)
- transcriptome (1)
- translational research (1)
- tumor-associated macrophage (1)
- ubiquitination (1)
- β3 adrenergic receptor (ADRB3) (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (21)
- Rudolf-Virchow-Zentrum (6)
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (5)
- Pathologisches Institut (4)
- Comprehensive Cancer Center Mainfranken (2)
- Institut für Rechtsmedizin (2)
- Julius-von-Sachs-Institut für Biowissenschaften (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Institut für Experimentelle Biomedizin (1)
- Institut für Pharmakologie und Toxikologie (1)
Schriftenreihe
EU-Project number / Contract (GA) number
- 678119 (2)
- 260464 (1)
- ERC-2018-ADG/NCI-CAD (1)
Chlamydia trachomatis (Ctr) can persist over extended times within their host cell and thereby establish chronic infections. One of the major inducers of chlamydial persistence is interferon-gamma (IFN-γ) released by immune cells as a mechanism of immune defence. IFN-γ activates the catabolic depletion of L-tryptophan (Trp) via indoleamine-2,3-dioxygenase (IDO), resulting in persistent Ctr. Here, we show that IFN-γ induces the downregulation of c-Myc, the key regulator of host cell metabolism, in a STAT1-dependent manner. Expression of c-Myc rescued Ctr from IFN-γ-induced persistence in cell lines and human fallopian tube organoids. Trp concentrations control c-Myc levels most likely via the PI3K-GSK3β axis. Unbiased metabolic analysis revealed that Ctr infection reprograms the host cell tricarboxylic acid (TCA) cycle to support pyrimidine biosynthesis. Addition of TCA cycle intermediates or pyrimidine/purine nucleosides to infected cells rescued Ctr from IFN-γ-induced persistence. Thus, our results challenge the longstanding hypothesis of Trp depletion through IDO as the major mechanism of IFN-γ-induced metabolic immune defence and significantly extends the understanding of the role of IFN-γ as a broad modulator of host cell metabolism.